Pierotti MA - Search Results

1

Re: Potential use of imatinib in Ewing's sarcoma: evidence for in vitro and in vivo activity.

Tamborini E, Bonadiman L, Albertini V, Pierotti MA, Pilotti S. Tamborini E, et al. Among authors: pierotti ma. J Natl Cancer Inst. 2003 Jul 16;95(14):1087-8; author reply 1088-9. doi: 10.1093/jnci/95.14.1087-a. J Natl Cancer Inst. 2003. PMID: 12865456 No abstract available.

2

Imatinib mesylate in chordoma.

Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S. Casali PG, et al. Among authors: pierotti ma. Cancer. 2004 Nov 1;101(9):2086-97. doi: 10.1002/cncr.20618. Cancer. 2004. PMID: 15372471 Free article.

3

KIT/Val654 Ala receptor detected in one imatinib-resistant GIST patient.

Tamborini E, Gabanti E, Lagonigro MS, Negri T, Pilotti S, Pierotti MA, Pricl S. Tamborini E, et al. Among authors: pierotti ma. Cancer Res. 2005 Feb 1;65(3):1115; author reply 1115. Cancer Res. 2005. PMID: 15705916 No abstract available.

4

Evidence for activation of KIT, PDGFRalpha, and PDGFRbeta receptors in the Ewing sarcoma family of tumors.

Bozzi F, Tamborini E, Negri T, Pastore E, Ferrari A, Luksch R, Casanova M, Pierotti MA, Bellani FF, Pilotti S. Bozzi F, et al. Among authors: pierotti ma. Cancer. 2007 Apr 15;109(8):1638-45. doi: 10.1002/cncr.22587. Cancer. 2007. PMID: 17342771 Free article.

5

T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense.

Negri T, Pavan GM, Virdis E, Greco A, Fermeglia M, Sandri M, Pricl S, Pierotti MA, Pilotti S, Tamborini E. Negri T, et al. Among authors: pierotti ma. J Natl Cancer Inst. 2009 Feb 4;101(3):194-204. doi: 10.1093/jnci/djn477. Epub 2009 Jan 27. J Natl Cancer Inst. 2009. PMID: 19176456

6

Re: A novel fusion gene, SYT-SSX4, in synovial sarcoma.

Agus V, Tamborini E, Mezzelani A, Pierotti MA, Pilotti S. Agus V, et al. Among authors: pierotti ma. J Natl Cancer Inst. 2001 Sep 5;93(17):1347-9. doi: 10.1093/jnci/93.17.1347. J Natl Cancer Inst. 2001. PMID: 11535711 No abstract available.

7

A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient.

Tamborini E, Bonadiman L, Greco A, Albertini V, Negri T, Gronchi A, Bertulli R, Colecchia M, Casali PG, Pierotti MA, Pilotti S. Tamborini E, et al. Among authors: pierotti ma. Gastroenterology. 2004 Jul;127(1):294-9. doi: 10.1053/j.gastro.2004.02.021. Gastroenterology. 2004. PMID: 15236194

8

KIT activation in soft tissue sarcomas.

Tamborini E, Bonadiman L, Moiraghi L, Pilotti S, Pierotti MA. Tamborini E, et al. Among authors: pierotti ma. Am J Clin Pathol. 2002 Sep;118(3):472-3; author reply 473. Am J Clin Pathol. 2002. PMID: 12219791 No abstract available.

9

Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma.

Tamborini E, Bonadiman L, Greco A, Gronchi A, Riva C, Bertulli R, Casali PG, Pierotti MA, Pilotti S. Tamborini E, et al. Among authors: pierotti ma. Clin Cancer Res. 2004 Feb 1;10(3):938-43. doi: 10.1158/1078-0432.ccr-03-0059. Clin Cancer Res. 2004. PMID: 14871970

10

Tumor location and detection of k-ras mutations in stool from colorectal cancer patients.

Frattini M, Balestra D, Pilotti S, Bertario L, Pierotti MA. Frattini M, et al. Among authors: pierotti ma. J Natl Cancer Inst. 2003 Jan 1;95(1):72-3; author reply 73. doi: 10.1093/jnci/95.1.72. J Natl Cancer Inst. 2003. PMID: 12509403 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters